Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2645 | 2 | MMP-1 | 93.0 | 48 | |||||||
| RA2708 | Tofacitinib | 0.3 | uM | 2 | MMP-1 | 1253.0 | 37 | ||||
| RA2708 | 2 | MMP-1 | 1413.0 | 45 | |||||||
| 0 | MMP-1 | 22.0 | 34 | ||||||||
| 0 | MMP-1 | 24.0 | 28 | ||||||||
| 0 | MMP-1 | 26.0 | 40 | ||||||||
| 0 | MMP-1 | 28.0 | 37 | ||||||||
| 0 | MMP-1 | 22.0 | 66 | ||||||||
| 0 | MMP-1 | 20.0 | 29 | ||||||||
| RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-1 | 6259.5 | 42 | ||||
| RA1869 | IKK16 | 2.0 | uM | 3 | MMP-1 | 4861.5 | 42 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-1 | 320.0 | 49 | ||||
| N2759 | IKK16 | 2.0 | uM | 3 | MMP-1 | 489.5 | 58 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-1 | 6469.0 | 35 | ||||
| RA1931 | IKK16 | 2.0 | uM | 3 | MMP-1 | 11288.0 | 48 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-1 | 1739.0 | 35 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | MMP-1 | 1274.0 | 37 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 3 | MMP-1 | 6147.5 | 36 | ||||
| RA1869 | 3 | MMP-1 | 6771.0 | 36 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 3 | MMP-1 | 646.0 | 33 | ||||
| N2759 | 3 | MMP-1 | 472.0 | 45 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 3 | MMP-1 | 6963.0 | 44 | ||||
| RA1931 | 3 | MMP-1 | 7222.5 | 62 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | MMP-1 | 1256.5 | 78 | ||||
| N2586 | 3 | MMP-1 | 819.0 | 50 |